|
NDUFS5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.95949999956835E-08 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.383630E-04 |
| Normal-vs-Stage2 |
2.406500E-02 |
| Normal-vs-Stage3 |
3.42050000001759E-06 |
| Normal-vs-Stage4 |
3.61970000000156E-05 |
| Stage1-vs-Stage2 |
7.066000E-01 |
| Stage1-vs-Stage3 |
2.353000E-01 |
| Stage1-vs-Stage4 |
5.418300E-02 |
| Stage2-vs-Stage3 |
2.103600E-01 |
| Stage2-vs-Stage4 |
6.571600E-02 |
| Stage3-vs-Stage4 |
3.904800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.42810000003379E-06 |
| Normal-vs-AfricanAmerican |
1.156990E-04 |
| Normal-vs-Asian |
4.208200E-01 |
| Caucasian-vs-AfricanAmerican |
1.319650E-02 |
| Caucasian-vs-Asian |
9.434200E-01 |
| AfricanAmerican-vs-Asian |
3.700400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.08989999994635E-06 |
| Normal-vs-Female |
1.78989999999324E-06 |
| Male-vs-Female |
3.278800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.539000E-03 |
| Normal-vs-Age(41-60Yrs) |
7.74869999999872E-05 |
| Normal-vs-Age(61-80Yrs) |
7.15850000054807E-07 |
| Normal-vs-Age(81-100Yrs) |
7.284200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.083600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.357000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.624400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.171600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.893800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.033400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
7.428600E-01 |
| Normal-vs-Grade 2 |
4.46410000000119E-05 |
| Normal-vs-Grade 3 |
4.18800000000497E-05 |
| Normal-vs-Grade 4 |
1.69646000000023E-05 |
| Grade 1-vs-Grade 2 |
4.350000E-02 |
| Grade 1-vs-Grade 3 |
3.706300E-02 |
| Grade 1-vs-Grade 4 |
1.401570E-03 |
| Grade 2-vs-Grade 3 |
8.836200E-01 |
| Grade 2-vs-Grade 4 |
3.373800E-02 |
| Grade 3-vs-Grade 4 |
4.374400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.174800E-04 |
| Normal-vs-ccB subtype |
1.151350E-04 |
| ccA subtype-vs-ccB subtype |
3.783800E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.780630E-04 |
| Normal-vs-N1 |
8.172500E-02 |
| N0-vs-N1 |
7.461200E-01 |
|
|
